Advantages and disadvantages of mouse models of chronic lymphocytic leukemia in drug discovery

EXPERT OPINION ON DRUG DISCOVERY

TAYLOR & FRANCIS LTD

1. Spanish Ministry of Science and Innovation [RTI2018-094584-B-I00]
2. Centro de Investigacion Biomedica en Red de Cancer (CIBERONC) [CB16/12/00334]
3. Generalitat de Catalunya [2017 SGR 1009]
4. Spanish Ministry of Science, Innovation and Universities [FPU19/03110]